CODX Sales General And Administrative To Revenue from 2010 to 2025
| CODX Stock | USD 0.75 0.05 7.14% |
Sales General And Administrative To Revenue | First Reported 2010-12-31 | Previous Quarter 2.09620689 | Current Value 1.99 | Quarterly Volatility 131.50762731 |
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
CODX | Sales General And Administrative To Revenue |
Latest Co Diagnostics' Sales General And Administrative To Revenue Growth Pattern
Below is the plot of the Sales General And Administrative To Revenue of Co Diagnostics over the last few years. It is Co Diagnostics' Sales General And Administrative To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
| Sales General And Administrative To Revenue | 10 Years Trend |
|
Sales General And Administrative To Revenue |
| Timeline |
CODX Sales General And Administrative To Revenue Regression Statistics
| Arithmetic Mean | 95.11 | |
| Geometric Mean | 16.60 | |
| Coefficient Of Variation | 138.27 | |
| Mean Deviation | 82.38 | |
| Median | 84.68 | |
| Standard Deviation | 131.51 | |
| Sample Variance | 17,294 | |
| Range | 404 | |
| R-Value | (0.31) | |
| Mean Square Error | 16,853 | |
| R-Squared | 0.1 | |
| Significance | 0.26 | |
| Slope | (9.07) | |
| Total Sum of Squares | 242,120 |
CODX Sales General And Administrative To Revenue History
About Co Diagnostics Financial Statements
Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Sales General And Administrative To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Sales General And Administrative To Revenue | 2.10 | 1.99 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.